• Home
  • About Us
  • Our Story

An origin story that created history

Dabur’s unending resolve to create products that are inspired by the science of nature, shines through its century old legacy. It is this undying commitment that has earned Dabur the largest herbal and natural product portfolio in the world.

With its country office in London, Dabur UK is a part of Dabur International, a completely owned subsidiary of Dabur India. The company's annual turnover exceeds US$1.2 Billion globally and enjoys a market cap of US$11 Billion.

His vision, our purpose

Founded by visionary Dr. S. K. Burman, with a mission to provide an effective and affordable cure for killer diseases such as cholera, malaria, and plague. His efforts led to the setting up of Dabur in 1884 to produce and dispense Ayurvedic medicines. Dabur rests on this strong foundation to deliver products of uncompromising quality. With 136 years of experience, today we are a globally recognized brand with offerings across multiple verticals.

The Historical Landmarks


Birth of Dabur

Dr. S. K. Burman launches his mission to make health care products in Calcutta.


Setting up a manufacturing plant

With growing popularity of Dabur products, Dr. Burman expands his operations by setting up a manufacturing plant for mass production of formulations.


Ayurvedic medicines

Dabur enters the specialised area of nature-based Ayurvedic medicines , for which standardised drugs are not available in the market.


Establishment of research laboratories

The need to develop scientific processes and quality checks for mass production of traditional Ayurvedic medicines leads to establishment of research laboratories.


Dabur India (Dr. S.K. Burman) Pvt. Ltd.

Dabur becomes a full-fledged company - Dabur India (Dr. S. K. Burman) Pvt. Ltd.


Sahibabad factory / Dabur Research & Development Centre (DRDC)

Commercial production starts in the new Sahibabad factory of Dabur, one of the largest and best equipped production facilities for Ayurvedic medicines. Launching of full-fledged research operations in pioneering areas of health care with establishment of the Dabur Research & Development Centre (DRDC).


Public Limited Company

Dabur becomes a Public Limited Company. Dabur India Ltd. comes into being after reverse merger with Vidogum Limited.


Cancer treatment

Dabur enters the specialised health care area of cancer treatment with its oncology formulation plant at Baddi in Himachal Pradesh.


Public issue

Dabur India Ltd. raises its first public issue. Due to market confidence in the Company, shares issued at a high premium are oversubscribed 21 times.


Joint Ventures

Extending its global partnerships, Dabur enters into a Joint Venture (JV) with Osem of Israel for food and Bongrain of France for cheese & other dairy products.


Dabur India Ltd’s turnover crosses the Rs 1,000 Crore mark

Dabur establishes its market leadership status with a turnover of Rs.1,000 crores. From a small beginning and upholding the values of its founder, Dabur now enters the august league of large corporate businesses.


Approves FCCB/GDR/ADR up to $200 million

Moving forward on the inorganic growth path Dabur India decides to raise upto $200 million from the international market through bonds, FCCBs, GDR, ADR, QIPs or any other securities.


Dabur Red Paste joins 'Billion Rupee Brand' club

One of its popular products, Dabur Red Paste enters the ‘Billion Rupee Brand’ club.


Dabur crosses Billion-Dollar turnover mark

Dabur India Ltd. surpasses the billion-dollar turnover mark during the 2011-12 fiscal to end the year on a high note with net sales of INR 5283.17 crores.


Market Capitalisation crosses the $5 Billion mark.


Dabur market cap stands at $12 Billion.